For US Healthcare Professionals Important Safety Information Full Prescribing Information

Why Choose CroFab?

CroFab Meets WHO Guidelines for Effective Snake Antivenom1

According to the World Health Organization (WHO), an effective antivenom is one derived from clinically relevant snakes native to the geographic region in which the antivenom is used.1

CroFab is the only antivenom derived from geographically and clinically relevant US snakes for comprehensive coverage of all North American pit viper envenomations.1,2

Cotton Mouth/Water Moccasin icon
Cotton Mouth/Water Moccasin photo thumbnail

Cottonmouth/
Water Moccasin

Mojave Rattlesnake icon
Mojave Rattlesnake photo thumbnail

Mojave
Rattlesnake

Eastern Diamondback icon
Eastern Diamondback photo thumbnail

Eastern
Diamondback

Western Diamondback icon
Western Diamondback photo thumbnail

Western
Diamondback

Cottonmouth
Water Moccasin - Coiled

Cottonmouth/
Water Moccasin

Rattlesnake
Mojave Rattlesnak Coiled

Mojave
Rattlesnake

Eastern Diamondback
Eastern Diamondback - Coiled

Eastern
Diamondback

Western Diamondback
Western Diamondback - Coiled for Strike

Western
Diamondback

CroFab Was Engineered to Neutralize a Broad Range of Clinically Relevant Toxins2

A Comprehensive Venomics Approach

Four snake species were strategically chosen based on their unique venom fingerprints, which together provide comprehensive coverage across the diverse venom compositions of North American pit vipers.2,3

The venom fingerprints of the four US pit vipers used to engineer CroFab

 

Hear why Dr. Thomas Arnold and Dr. William Banner choose CroFab.

 

CroFab efficacy checkmark icon

CroFab is clinically proven to achieve initial control of envenomation1

Examine the Data
IgG antibody icon

CroFab rapidly binds to and neutralizes venom toxins2

See the MOA
CroFab safety clipboard icon

CroFab safety is backed by more than 20 years of clinical experience2

View Safety Profile
REFERENCES

1. WHO Expert Committee on Biological Standardization. WHO Technical Report Series, No. 1004, Annex 5; 2017. Accessed September 10, 2021. https://www.who.int/biologicals/WHO_TRS_1004_web.pdf  2. CroFab® [prescribing Information]. BTG International Inc.; August 2018. 3. Data on file. BTG International Inc.